TISSIUM

📍 Paris, France🗓 Founded 2013👥 145 employees💰 Last funded Dec 2025
Medical Equipment Manufacturing🌐 tissium.com
Website LinkedIn
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
6
Total investors
1
Early stage
1
Mid stage
3
Late stage
2013
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
4
United States
1
United Kingdom
1
Investor activity2013–2025 · investors recorded per year
2013120171201912021220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in TISSIUM?
TISSIUM has 6 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 3 late-stage investors.
When did TISSIUM last raise funding?
The most recent investment in TISSIUM recorded on gritt.io was in December 2025.
When was TISSIUM founded?
TISSIUM was founded in 2013.
What industry is TISSIUM in?
TISSIUM operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is TISSIUM based?
TISSIUM is headquartered in Paris, France.